AI in Oncology Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The AI in Oncology market is segmented by Component (Software Solutions, Hardware, and Services), Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, and Other Cancer Types), Treatment Type (Chemotherapy, Radiotherapy, Immunotherapy, and Other Treatment Types), Application (Cancer Detection, Drug Discovery, Drug Development, and Other Applications), and Geography (North America (United States, Canada, and Mexico), Europe (Germany, United Kingdom, France, Italy, Spain, and Rest of Europe) Asia-Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia-Pacific), Middle East and Africa (GCC, South Africa, and Rest of Middle East and Africa), and South America (Brazil, Argentina, and Rest of South America). The report offers the value (in USD million) for the above segments.

AI in Oncology Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

AI in Oncology Industry Overview

The AI in Oncology Market is fragmented due to the presence of several companies operating globally and regionally. The competitive landscape includes an analysis of a few international as well as local companies which hold market shares and are well known, including Azra AI, IBM Corporation, Siemens Healthineers AG, Intel Corporation, GE Healthcare, NVIDIA Corporation, Digital Diagnostics Inc., ConcertAI LLC, Median Technologies Inc, and PathAI.

AI in Oncology Market Leaders

  1. Azra AI

  2. IBM Corporation

  3. Siemens Healthineers AG

  4. Intel Corporation

  5. GE Healthcare

  6. *Disclaimer: Major Players sorted in no particular order
Artificial Intelligence in Oncology Market Concentration